Announce Date | 05/06/2024 |
EPS Normalized Actual | $-3.50502 (Beat by $0.99498) |
EPS GAAP Actual | $-3.50502 (Beat by $0.99498) |
Revenue Actual | $0.138925B |
Revenue Surprise | Beat by $138.925M |
Announce Date | 06/30/2024 (Pre-Market) |
EPS Normalized Estimate | $1.34259 |
EPS GAAP Estimate | $1.34259 |
Revenue Estimate | $0.2839515B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2025 | 0 | INF | 0 | 0 | 1 |
Dec 2024 | -13.39667 | -0.37 | -14.02 | -12.18 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2022 (Mar 2022) | -0.7 | -0.7 | 0.138925B | -7.3% | 138.93M |
FQ4 2021 (Dec 2021) | 0.0211094 | 0.0211094 | 0.155763B | 100% | 155.76M |
FQ3 2021 (Sep 2021) | -1.65056 | -1.65056 | 0.159013B | 100% | 159.01M |
FQ2 2021 (Jun 2021) | -0.028102 | -0.028102 | 0.164033B | 34.31% | 164.03M |
FQ4 2020 (Dec 2020) | -0.00808 | -0.00808 | 0B | NAN% | 0M |
FQ3 2020 (Sep 2020) | -0.0062211 | -0.0062211 | 0B | NAN% | 0M |
FQ2 2020 (Jun 2020) | 0.013939 | 0.013939 | 0.107754B | 100% | 107.75M |
FQ3 2022 (Sep 2022) | -0.57 | -0.57 | 0.142313B | -11.73% | 142.31M |
FQ4 Announce Date
06/30/2024 (Pre-Market)
Consensus EPS Estimates
1.34259
Consensus Revenue Estimates
0.2839515B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2025 (Oct 2025) | -3.26 | -- | -3.27204 | -3.24796 | 0 |
FQ3 2025 (Jul 2025) | -2.59 | -- | -2.59957 | -2.58043 | 0 |
FQ2 2025 (Jun 2025) | -2.59 | -- | -2.6009 | -2.5791 | 0 |
FQ1 2025 (Mar 2025) | -3.58 | -- | -3.59506 | -3.56494 | 0 |
FQ4 2024 (Oct 2024) | -3.84 | -- | -3.85419 | -3.82581 | 1 |
FQ3 2024 (Jul 2024) | -3.325 | -- | -3.33728 | -3.31272 | 1 |
FQ2 2024 (Jun 2024) | 1.34259 | -- | 1.35834 | 1.32684 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2025 (Oct 2025) | 0.2B | -- | 0.2B | 0.2B | 0 |
FQ3 2025 (Jul 2025) | 0.2B | -- | 0.2B | 0.2B | 0 |
FQ2 2025 (Jun 2025) | 0.2B | -- | 0.2B | 0.2B | 0 |
FQ1 2025 (Mar 2025) | 0.19B | -- | 0.19B | 0.2B | 0 |
FQ4 2024 (Oct 2024) | 0.19B | -- | 0.19B | 0.19B | 1 |
FQ3 2024 (Jul 2024) | 0.19B | -- | 0.19B | 0.19B | 1 |
FQ2 2024 (Jun 2024) | 0.28B | -- | 0.25B | 0.32B | 18 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
2
EPS # of Misses
6
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
0
Revenue # of in-lines
2
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2022 (Mar 2022) | -0.7 | -0.7 | 100% | |
FQ4 2021 (Dec 2021) | 0.0211094 | 0.0211094 | 100% | |
FQ3 2021 (Sep 2021) | -1.65056 | -1.65056 | 100% | |
FQ2 2021 (Jun 2021) | -0.028102 | -0.028102 | 100% | |
FQ4 2020 (Dec 2020) | -0.00808 | -0.00808 | 100% | |
FQ3 2020 (Sep 2020) | -0.0062211 | -0.0062211 | 100% | |
FQ2 2020 (Jun 2020) | 0.013939 | 0.013939 | 100% | |
FQ3 2022 (Sep 2022) | -0.57 | -0.57 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2022 (Mar 2022) | $0B | $0.14B | $138.93M | 100% |
FQ4 2021 (Dec 2021) | $0B | $0.16B | $155.76M | 100% |
FQ3 2021 (Sep 2021) | $0B | $0.16B | $159.01M | 100% |
FQ2 2021 (Jun 2021) | $0B | $0.16B | $164.03M | 100% |
FQ4 2020 (Dec 2020) | $0B | $0B | $0M | NAN% |
FQ3 2020 (Sep 2020) | $0B | $0B | $0M | NAN% |
FQ2 2020 (Jun 2020) | $0B | $0.11B | $107.75M | 100% |
FQ3 2022 (Sep 2022) | $0B | $0.14B | $142.31M | 100% |